Last checked at 10 Jun 2021 12:34
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 09 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
5,711,324 | 2.27% | 121,170 | 0.05% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
82,054 | 0.03% | 5,098,991 | 2.02% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
5,793,378 | 2.30% | 5,220,161 | 2.07% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 640 | 10.5400 GBP |
Purchase | 793 | 10.4750 GBP |
Purchase | 907 | 10.4850 GBP |
Purchase | 983 | 10.5300 GBP |
Purchase | 1,214 | 10.4975 GBP |
Purchase | 1,221 | 10.4805 GBP |
Purchase | 1,311 | 10.4839 GBP |
Purchase | 2,332 | 10.5045 GBP |
Purchase | 2,881 | 10.4866 GBP |
Purchase | 3,580 | 10.4881 GBP |
Purchase | 5,620 | 10.4904 GBP |
Purchase | 7,392 | 10.5007 GBP |
Purchase | 10,140 | 10.4997 GBP |
Purchase | 15,349 | 10.4986 GBP |
Purchase | 23,060 | 10.5054 GBP |
Purchase | 41,520 | 10.4808 GBP |
Purchase | 50,328 | 10.4800 GBP |
Purchase | 90,875 | 10.5100 GBP |
Purchase | 131,484 | 10.4977 GBP |
Sale | 1 | 10.5000 GBP |
Sale | 260 | 10.4900 GBP |
Sale | 793 | 10.4750 GBP |
Sale | 907 | 10.4850 GBP |
Sale | 1,530 | 10.4800 GBP |
Sale | 1,883 | 10.5347 GBP |
Sale | 2,452 | 10.5081 GBP |
Sale | 2,559 | 10.4927 GBP |
Sale | 3,765 | 10.4984 GBP |
Sale | 3,918 | 10.5119 GBP |
Sale | 3,952 | 10.5080 GBP |
Sale | 5,481 | 10.4866 GBP |
Sale | 6,091 | 10.4752 GBP |
Sale | 10,914 | 10.4808 GBP |
Sale | 11,659 | 10.5100 GBP |
Sale | 14,684 | 10.4789 GBP |
Sale | 96,219 | 10.5072 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
SWAP | Long | 3,003 | 10.5074 GBP |
CFD | Long | 10,282 | 10.4946 GBP |
SWAP | Long | 10,567 | 10.4955 GBP |
CFD | Short | 2,332 | 10.5045 GBP |
SWAP | Short | 15,978 | 10.4968 GBP |
SWAP | Short | 15,999 | 10.4953 GBP |
SWAP | Short | 31,037 | 10.5110 GBP |
SWAP | Short | 48,267 | 10.4952 GBP |
SWAP | Short | 84,801 | 10.4949 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 10 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005507/en/
Copyright Business Wire 2021